Ipsen Press Releases | Latest News & Updates

Topics

Period

Filter by

Reset

Showing: 1 – 5 of 253 Press Releases

Show

Sort

21 August 2026

21 August 2026

Download Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

30 July 2026

30 July 2026

Download Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

29 July 2026

29 July 2026

Download Ipsen nominates Catherine Bradley to its Board of Directors as independent Director

Ipsen nominates Catherine Bradley to its Board of Directors as independent Director

24 July 2026

24 July 2026

Download Ipsen provides update on Phase III BOLD trial in biliary atresia

Ipsen provides update on Phase III BOLD trial in biliary atresia

22 July 2026

22 July 2026

Download Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

Your dedicated contacts

Media Relations

+33 1 58 33 50 00

IpsenMediaRelations@ipsen.com

Add to contacts

Stay updated

Register to receive our latest news